Product Information

METRONIDAZOLE VAGINAL 0.75% GL is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.1470 per GM under NDC 45802013970. Its NADAC has been published 379 times since Aug 21, 2019.

FDA first approved this application on Jul 2, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METRONIDAZOLE VAGINAL 0.75% GL

metronidazole
$0.1470per GM

Strength

7.5 mg/g

NDC

45802013970

Classification

Generic

Dosage Form

GEL

Route

VAGINAL

Effective Date

11/18/2026

Active Ingredients

METRONIDAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA211786

FDA Approved

7/2/2019

TE Code

AB

On Market Since

7/8/2019

Pharmacological Classes

Price Statistics

The NADAC for METRONIDAZOLE VAGINAL 0.75% GL has been published 379 times since Aug 21, 2019, and over the history we have for it it has declined 84.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1470 per GM
All-time high$1.1341 (Feb 12, 2020)
All-time low$0.1405 (Jul 22, 2026)
52-week high$0.1847
52-week low$0.1405
Median price$0.4792
Average price$0.5416
Largest weekly change-40.7% (Nov 20, 2024)
Weeks tracked379
Tracking sinceAug 21, 2019

Price History

1W

+0.5%

1M

+4.6%

3M

+4.0%

6M

-0.0%

1Y

-17.3%

3Y

-68.5%

5Y

-82.4%

All

-84.1%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METRONIDAZOLE VAGINAL 0.75% GL?

The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE VAGINAL 0.75% GL, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.1470 per GM (NDC 45802013970), effective Nov 18, 2026.

How has the price of METRONIDAZOLE VAGINAL 0.75% GL changed over time?

Over the history we have for it, the NADAC for METRONIDAZOLE VAGINAL 0.75% GL has declined 84.1%. It has been tracked across 379 weekly CMS publications since Aug 21, 2019.

What are the highest and lowest recorded NADAC prices for METRONIDAZOLE VAGINAL 0.75% GL?

Since Aug 21, 2019, the NADAC for METRONIDAZOLE VAGINAL 0.75% GL has ranged from a low of $0.1405 (Jul 22, 2026) to a high of $1.1341 (Feb 12, 2020), with a median of $0.4792 per GM.

Are there cheaper alternatives to METRONIDAZOLE VAGINAL 0.75% GL?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METRONIDAZOLE VAGINAL 0.75% GL in a comparable dosage form, but none are currently priced below it.

Who manufactures METRONIDAZOLE VAGINAL 0.75% GL?

METRONIDAZOLE VAGINAL 0.75% GL (NDC 45802013970) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.